PRMT7 antibody (full length)
Quick Overview for PRMT7 antibody (full length) (ABIN7878879)
Target
See all PRMT7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- PRMT7 Antibody
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the PRMT7 antibody.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal dilution of the PRMT7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the PRMT7 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
-
Alternative Name
- PRMT7
-
Background
- Arginine methylation is an irreversible protein modification catalyzed by Arginine methyltransferases, such as PRMT7, which uses S-adenosylmethionine (AdoMet) as the methyl donor. Arginine methylation is implicated in signal transduction, RNA transport and RNA splicing. PRMT7 has two methyltransferase domains, each containing a putative AdoMet-binding motif. The N-terminal methyltransferase domain closely resembles the catalytic core of PRMT5, and the C-terminal domain is most similar to that of PRMT1. Three PRMT7 splice variants have been identified by database analysis. PRMT7 is localized to the nucleus and cytoplasm and moderate expression is observed in adult brain and lung tissues.
-
UniProt
- Q9NVM4
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-